sulfinpyrazone has been researched along with Respiratory Insufficiency in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodvien, R | 1 |
| Salzman, EW | 1 |
| Cerskus, AL | 1 |
| Ali, M | 1 |
| Zamecnik, J | 1 |
| McDonald, JW | 1 |
2 other studies available for sulfinpyrazone and Respiratory Insufficiency
| Article | Year |
|---|---|
Thrombotic and hemorrhagic problems in surgery.
Topics: Aspirin; Blood Coagulation Factors; Dextrans; Extracorporeal Circulation; Female; Hemostasis; Hepari | 1978 |
Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits.
Topics: Animals; Arachidonic Acids; Blood Platelets; Female; Indomethacin; Infusions, Parenteral; Platelet A | 1978 |